Call Us
888.433.2300
Also Available In
- MFR:
- COV-13C20E
- Medex SKU:
- BTX-COV-13C20E
- Packing Info:
- 20/Pack
- Usually Ships:
- 1 - 2 Business Days
- Freight Quote Button:
- False
- Notice:
- Due to regulatory requirements, this item can only be shipped to customers who have a valid Medical license on file. To add your license information, please click here
Description
The rapid COVID-19 Antigen Test is FDA Emergency Use Authorized, CLIA Waived, and allows for an efficient, accurate, and cost-friendly method of detection at the Point-of-Care. In just 10 minutes, the test is able to detect the SARS-CoV-2 nucleocapsid protein antigen through visual interpretation of colored lines.The SARS-CoV-2 nucleocapsid protein antigen is generally detectable in nasopharyngeal swab specimens during the acute phase of infection. This test is intended for individuals suspected of COVID-19 within five days of symptom onset.
Independent Clinical Agreement Validation
The COVID-19 IgG/IgM Rapid Test Device was tested at the Frederick National Laboratory for Cancer Research (FNCLR) sponsored by the National Cancer Institute. The test was validated against a panel of previously frozen samples consisting of 30 SARS-CoV-2 antibody-positive serum samples & 80 antibody-negative serum and plasma samples. The table to the right highlights the critical data from the study.